Introduction
were used as control group. At 10 and 53 days after the last immunization 4 mice in 251 each group were sacrificed and spleens processed for Intracellular Cytokine Staining 252 (ICS) assays to measure the adaptive and memory immune responses against HIV-1 253 antigens, respectively. Two independent experiments have been performed for the 254 different groups. 255
256

Intracellular Cytokine Staining assay (ICS) 257
The magnitude, polyfunctionality and phenotype of the HIV-1 specific T cell responses 258 were analyzed by ICS. After an overnight rest, 5 x 10 6 splenocytes (depleted of red 259 blood cells) were stimulated during 6 hours in complete RPMI 1640 media containing 1 260 μl/ml Golgiplug (BD Biosciences) and 5 μg/ml of the different HIV-1 peptide pools. At 261 the end of the stimulation period, cells were washed, stained for the surface markers, 262 permeabilized (Cytofix/Cytoperm kit; BD Biosciences) and stained intracellularly using 263 the appropriate fluorochromes. For functional analyses the following fluorochromes-264 conjugated antibodies were used: CD3-FITC, CD4-Alexa 700, CD8-PerCP or -V500, 265
IL-2-PE or -APC, IFN-γ-APC or -PECy7 and TNF-α-PECy7 or -PE. In addition, for 266 phenotypic analyses the following antibodies were used: CD62L-FITC and CD44-267 SPRD. Dead cells were excluded using the violet LIVE/DEAD stain kit (Invitrogen). All 268 antibodies were from BD Biosciences. Cells were acquired using an LSRII flow 269 cytometer (BD Immunocytometry Systems). Analyses of the data were performed using 270 the FlowJo software version 8.5.3 (Tree Star, Ashland, OR). The number of 271 lymphocyte-gated events ranged between 10 5 and 10 6 . After gating, Boolean 272 combinations of single functional gates were then created using FlowJo software to 273 determine the frequency of each response based on all possible combinations of 274 cytokine expression or all possible combinations of differentiation marker expression. 275
Background responses detected in negative control samples were subtracted from 276 those detected in stimulated samples for every specific functional combination. 277
ELISPOT assay 278
The VACV-specific cellular immune response was evaluated by fresh IFN-γ ELISPOT 279 as previously described (28). The E3 and F2(G) peptides were resuspended in RPMI 280 1640 supplemented with 10% FCS and added to the cells at a final concentration of 5 281 µg/ml. 282
Antibody measurements by ELISA 283
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Binding antibodies to Env and vaccinia virus proteins in serum were assessed by 284 ELISA as previously described (17) . Serum from naïve and immunized mice were 285 serially two-fold diluted in duplicate and reacted against 2 µg/ml of the recombinant 286 97CN54 gp140 purified protein (clade C) (kindly provided by Simon A. Jeffs, Imperial 287
College London, UK). The antibody titers of Env-specific IgG was defined as the last 288 dilution of serum that gives 3 times the mean OD450 value of the naïve control. To 289 evaluate the anti-VACV humoral response serum from individual mice was reacted at 290 1:100 dilution in triplicate against 10 µg/ml of extract from BSC-40 cells infected (5 291 pfu/cell) for 24 h with VACV WR. 292
Data analysis and statistics 293
For the statistical analysis of ICS data we used a novel approach that corrects 294 measurements for the medium response (RPMI) and at the same time allows the 295 calculation of confidence intervals and p-values of hypothesis tests (15, 34 
Results
305
Generation and in vitro characterization of NYVAC-C deletion mutants 306 NYVAC-C-∆B8R, NYVAC-C-∆B19R and NYVAC-C-∆B8R/∆B19R deletion mutants 307 were generated as detailed under Materials and Methods using as parental virus the 308 recombinant NYVAC-C that expresses the HIV-1 Env, Gag, Pol and Nef antigens from 309 clade C (17). The correct generation and purity of each deletion mutant was confirmed 310 by PCR using primers for the B8R or B19R locus, showing correct deletion of the viral 311 genes ( Figure 1A ). Analysis by Western blot verified that the deletion mutants express 312 the HIV-1 proteins gp120 and GPN at the same level as their parental virus NYVAC-C 313 ( Figure 1B) . Moreover, analysis by immunostaining showed that all virus plaques have 314 immunoreactivity to both anti-WR and anti-gp120 antibodies as NYVAC-C (not shown), 315 demonstrating the stability of the viruses. To determine if single or double deletions of 316 B8R and B19R genes affect virus replication in cell cultures we compared the growth 317 kinetics in CEF of all deletion mutants with their parental virus NYVAC-C. Figure 1C  318 showed that the kinetics of growth were similar between parental and deletion mutants. binding to its receptor, we analyzed the phosphorylation levels of STAT1 in extracts 323 from human PBMCs infected (5 pfu/cell) for 4 h with the parental and deletion mutants. 324
In contrast with NYVAC-WT, NYVAC-C or NYVAC-C-∆B8R, viruses lacking the B19R 325 or with double deletion had high levels of P-STAT1 indicating activation of this signaling 326 pathway ( Figure S1B ). 327
Deletion of the viral genes B8R and/or B19R in NYVAC-C induced high, broad 328
and polyfunctional HIV-1-specific T cell adaptive immune responses 329
To assay in vivo the effect of the single and double deletions of B8R and B19R 330 vaccinia genes in the genome of the NYVAC-C recombinant, we analyzed the HIV-1-331 specific immune responses elicited in mice using a DNA prime/Pox boost approach. 332 BALB/c mice, 4 in each group, were immunized according to the schedule shown in 333 DNA (DNA-φ) and boosted with the non-recombinant NYVAC-WT were used as control 342 group. As shown in Figure 2B , in all the immunization groups the magnitude of the HIV-343 1-specific CD4+ and CD8+ T cell responses, determined as the sum of the individual 344 responses obtained for Env, Gag and GPN peptide pools, was significantly higher than 345 that obtained in the control group DNA-φ/NYVAC-WT (p<0.05). The CD4+ T cell 346 responses were mainly directed against the Env pool with no differences between the 347 groups boosted with the NYVAC-C deletion mutants and the group boosted with the 348 parental NYVAC-C. In contrast, the CD8+ T cell responses were higher in magnitude, 349 and significantly higher in the groups boosted with the NYVAC-C deletion mutants than 350 in the group boosted with the parental NYVAC-C. Clearly, the deletions induced a 351 significant enhancement in the magnitude of the CD8+ T cell responses against the 352 Env pool (p<0.005) whereas the anti-GPN responses were not significantly affected.
353
No specific CD4+ and CD8+ T cell responses were detected against the Gag pool. 354
Representative functional profiles of Env-induced CD8+ T cell responses were shown 355 in Figure 2C . Similar findings were observed in two independent experiments. 356
The quality of a T cell response can be characterized in part by the pattern of cytokine 357 production. On the basis of the analysis of IL-2, TNF-α and IFN-γ secretion, seven 358 distinct HIV-1-specific CD4+ and CD8+ T cell populations were identified (Figure 3) . 359
The percentages of cells producing cytokines obtained in the DNA-φ/NYVAC-WT 360 control populations were subtracted in all the groups in order to remove the non-361 specific responses detected as background. Vaccine-induced CD4+ T cell responses 362
were highly polyfunctional in all the immunization groups, with more than 60% of CD4+ 363 T cells exhibiting two or three functions. CD4+ T cells producing IL-2+TNF-α+IFN-γ+; 364 IL-2+TNF-α+ and only IL-2 were the most representative populations induced by the 365 parental NYVAC-C and the deletion mutants, although the percentages of cells 366 producing cytokines were low ( Figure 3A) . The HIV-1-specific CD8+ T cell responses 367 were also highly polyfunctional, being the proportions of cells producing the different 368 numbers of cytokines similar in all the immunization groups. CD8+ T cells producing IL-369 2+TNF-α+IFN-γ+; IFN-γ+TNF-α+ and only IFN-γ were the most representative 370 populations induced by the parental NYVAC-C and the deletion mutants, but the 371 absolute frequencies of each population were significantly higher in groups boosted 372 with the NYVAC-C-∆B8R and NYVAC-C-∆B8R/∆B19R deletion mutants compared with 373 the parental NYVAC-C ( Figure 3B ). Overall, these results indicate that single and/or 374 double deletion of the viral genes B8R and B19R improved the magnitude and quality 375 of the HIV-1-specific adaptive T cell immune responses. 376
Single and/or double deletion of the viral genes B8R and B19R impact on the 377
CD8+ T cell memory phase of the immune response 378
Phenotypic analysis of memory vaccine-induced T cell responses was carried out 53 379 days after the last immunization by polychromatic ICS assay. Splenocytes from 380 immunized mice were stimulated with the HIV-1 peptide pools Env, Gag and GPN for 6 381 hours and stained with specific antibodies to identify T cell lineage (CD4 and CD8), 382 responding cells (IL-2, IFN-γ and TNF-α) as well as memory stages (CD44 and 383
CD62L). 384
The magnitude of the memory HIV-1-specific CD4+ and CD8+ T cell responses, 385 determined as the sum of the individual responses obtained for Env, Gag and GPN 386 peptide pools, were significantly higher in all the groups boosted with the parental or 387 the deletion NYVAC-C mutants than in the control group DNA-φ/NYVAC-WT (p<0.05) 388 We also determined the phenotype of the memory responses by measuring the 406 expression of CD62L and CD44 in the HIV-1-specific T cells. We chose to monitor the 407 expression of CD62L because it is a key marker that segregates the effector and 408 central memory T cell subsets in combination with CD44, which is expressed at high 409 levels in all effector and central memory, but not in naïve T cells (51 responses elicited by NYVAC-C and the deletion mutants were predominantly TEM 413 ( Figure S2) . Similarly, for CD8 T cells the HIV-1-specific memory responses induced by 414 NYVAC-C and the deletion mutants were TEM, but some differences were observed 415 between the groups. After NYVAC-C boost, 69.2% and 53.1% of the CD8+ T cells 416 against Env and GPN pools respectively were TEM, whereas the single or double 417 deletion of B8R and B19R increased these populations up to 90% ( Figure 4C) . 418
To analyse the quality of the HIV-1-specific memory responses, we evaluated the IL-2, 419 TNF-α and IFN-γ secretion in both CD4 and CD8 T subsets. Vaccine-induced CD4+ T 420 cell memory responses were similarly polyfunctional in all the immunization groups. 421 CD4+ T cells producing IL-2+TNF-α+ and only TNF-α were the most representative 422 populations induced by the recombinant viruses ( Figure 5A ). In contrast, the HIV-1-423 specific CD8+ T cell memory responses were improved by the use of the deletion 424 mutants in terms of both magnitude and polyfunctionality. The percentage of CD8+ T 425 cells producing IL-2+TNF-α+IFN-γ+; IFN-γ+TNF-α+ and only TNF-α were significantly 426 increased in animals boosted with the deletion mutants ( Figure 5B ). Overall, these 427 results revealed that single and/or double deletion of the viral genes B8R and B19R 428 impact on the CD8+ T cell memory phase of the immune response changing the 429 contraction phase, the memory differentiation, the magnitude and the polyfunctionality 430
pattern. 431
Deletion of the viral genes B8R and/or B19R in NYVAC-C does not affect the anti-432
HIV-1 gp120 humoral response 433
Since cells infected with NYVAC-C release monomeric gp120 (17), we evaluated the 434 impact of the deletion of viral genes B8R and/or B19R on the humoral responses at 435 days 25 and 68. We quantified by ELISA the Env-specific IgG titers against the purified 436 gp140 protein from the HIV-1 isolate CN54 (clade C) ( Figure 6 ). In all the groups 437 boosted with the deletion mutants the levels of anti-gp140 antibodies were similar to 438 those obtained in animals immunized with the parental NYVAC-C at both times 439 assayed (days 25 and 68) indicating that deletion of the viral genes B8R and/or B19R 440 has no effect on the humoral immune response induced in mice. optimal environment for the activation and differentiation of high quality HIV-1-specific 503
CD8+ T cells. 504
The efficacy of viral vaccines depends in part on the generation of a pool of potent 505 memory T cells ready to expand rapidly upon re-exposure to the antigen. Here we 506 observed that the CD8+ T cells induced after booster with the deletion mutants 507 underwent higher expansion and lower contraction than the CD8+ T cells induced after 508 the boost with the parental NYVAC-C, which resulted in a 2-5 fold increase of HIV-1 509 specific memory responses. The pattern of contraction exhibited by the CD8+ T cells 510 activated by the deletion mutants, and in particular by NYVAC-C-∆B8R or NYVAC-C-511 ∆B8R/∆B19R, were similar to that observed in homologous and heterologous 512 immunizations with Ad5 vector (40), or after immunization with live attenuated influenza 513 viruses that express altered NS1 protein, which is known to act as inhibitor of host IFN 514 responses (32), demonstrating the critical role of IFNs in the generation of an effective 515 immune responses. It has been described that optimal priming of both CD8 and CD4 T 516 cell responses involves direct signaling through the IFN type I receptor (IFNα/βR) (11, 517
21, 25), while IFN type II receptor signaling in CD8 T cells is dispensable for its 518
expansion, contraction and memory differentiation (46). Additionally, the CD8+ T cells 519 activated by the deletion mutants have enhanced differentiation to an effector memory 520 phenotype and enhanced polyfunctionality compared with the CD8+ T cells activated 521 by the parental NYVAC-C. The relevance of the effector memory T cells on the early 522 control of highly pathogenic SIV was recently described (19). Previous data about VACV vIFNα/βR or vIFNγR functions on vector immunogenicity 545 after their blockade did not reveal any positive results (12, 22, 54) . In these studies, the 546 authors used different replication competent VACV strains such as WR (54), Lister (12) 547 and Wyeth (22) that still retain the rest of the genes involved in VACV evasion of IFN-548 signaling pathways. It is known that in addition to the B8R and B19R, the products of 549 the genes E3L, K3L, H1L, C7L and more recently C6L, act within the infected cells 550 blocking IFN-signaling cascade or IFN-induced antiviral state (16, 37, 52). The need for 551 the virus to express so many different non-redundant viral inhibitors of host signaling 552 cascades may be due to the pressure that the host innate immune system applies. It is 553 plausible that the inhibition exerted by a single viral protein is not complete, particularly 554 at early stages of infection, thus requiring the expression of several different factors 555 targeting components of the same pathway to have an additive effect. In the previous 556 studies, it was evident that a single deletion on a replication competent VACV strain 557 does not improve the capacity of the host cells for priming effective anti-viral 558 responses. However, in our study we have used as parental virus the attenuated 559 NYVAC strain that does not express the functions of the genes K1L, C6L and C7L. As 560 we have shown here, the deletion of B8R and/or B19R in the NYVAC-C genome 561 adaptive immune responses, the magnitude and polyfunctionality were NYVAC-C-566 ∆B8R/∆B19R>∆B8R>∆B19R >parental. In the case of memory immune responses, the 567 magnitude was higher in the order NYVAC-C-∆B8R>∆B8R/∆B19R>∆B19R >parental; 568 for the effector phenotype and specifically for GPN responses it followed NYVAC-C-569 ∆B8R/∆B19R>∆B19R>∆B8R >parental; for the contraction phase and polyfunctionality 570 the order was NYVAC-C-∆B8R>∆B8R/∆B19R>∆B19R >parental. Clearly, the single 571 
